Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 10/20 | 0.33 |
| ▸ | JAK3 | P52333 | 3/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.31 |
| ▸ | CDK7 | P50613 | 1/20 | 0.31 |
| ▸ | CDK9 | P50750 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20314878 | 0.80 | KRAS (0.38) | KRASJAK3BTKFGFR1 | |
| SCHEMBL20314897 | 0.70 | BTK (0.41) | KRASJAK3BTK | |
| SCHEMBL20326222 | 0.68 | JAK3 (0.44) | KRASJAK3BTK | |
| SCHEMBL22222691 | 0.67 | JAK3 (0.47) | JAK3BTK | |
| SCHEMBL23865962 | 0.67 | JAK3 (0.47) | JAK3BTK | |
| SCHEMBL21787541 | 0.65 | PIK3CD (0.39) | KRASJAK3BTK | |
| SCHEMBL24518644 | 0.62 | TDP1 (0.36) | JAK3BTKFGFR1 | |
| SCHEMBL21610062 | 0.62 | JAK3 (0.40) | KRASJAK3BTK | |
| SCHEMBL24127287 | 0.61 | KMT2A (0.40) | — | |
| SCHEMBL31281268 | 0.61 | JAK3 (0.44) | KRASJAK3BTKFGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001269-A1 | BENZOISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER | Amgen Inc. (US) | 2022-05-25 | — | — | EP | disclosed |